Evidence mapPaperPMID 35677177Full record

SynthesisComputational and mathematical methods in medicine2022

Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease.

Yuanshe Huang, Xiaodong Wang, Lai Zhang, Ke Zheng, Jie Xiong, Jing Li, Chunlei Cong, Zhaomiao Gong, Jingxin Mao

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 7 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 7 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Hepatoprotective Effect ofJournal of microbiology and biotechnology · 2024
    Article
  17. The Efficacy ofMetabolites · 2024
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Yuanshe HuangAnshun University, Guizhou, Anshun 561000, China.
Xiaodong WangChongqing Medical and Pharmaceutical College, Chongqing 400030, China.
Lai ZhangAnshun University, Guizhou, Anshun 561000, China.
Ke ZhengDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing 400016, China.
Jie XiongDepartment of Pharmacy, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders/Chongqing Key Laboratory of Pediatrics/Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Jing LiAnshun University, Guizhou, Anshun 561000, China.
Chunlei CongAnshun University, Guizhou, Anshun 561000, China.ORCID https://orcid.org/0000-0001-9257-9993
Zhaomiao GongChongqing Medical and Pharmaceutical College, Chongqing 400030, China.ORCID https://orcid.org/0000-0001-9089-6514
Jingxin MaoCollege of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.ORCID https://orcid.org/0000-0002-2813-1702
Anshun University · CNChongqing Medical and Pharmaceutical College · CNSouthwest University · CNChildren's Hospital of Chongqing Medical University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease in the world. The pathogenesis of NAFLD is complex and multifactorial. Clinical studies have shown that alterations in the gut microbiota play a key role in NAFLD. The purpose of this study was to analyze the effect of probiotic supplementation on the treatment of NAFLD patients based on various indicators. Methods: We conducted a meta-analysis investigating the relationship between NAFLD and probiotic supplementation. Embase, PubMed, and Web of Science databases were searched by computer, and then, eligible studies were identified. Finally, a total of high-quality randomized controlled trials were selected involving 1403 participants. Meta-analysis was performed using the RevMan 5.3 software which was systematically searched for works published through Dec. 1, 2021, in the present study. Results: The meta-analysis results showed that the probiotics supplementation improved hepatocyte injury and significantly reduced the level of ALT ( Conclusion: The present study suggests that probiotics therapy may improve liver enzyme levels, regulated lipid metabolism, reduced insulin resistance, and improved inflammation in NAFLD patients. It supports the potential role of probiotics supplementation in the treatment of NAFLD.

Indexed as

Insulin ResistanceNon-alcoholic Fatty Liver DiseaseProbioticsHumansInflammationInsulinLiverInsulin

Identifiers

PMID35677177
PMCPMC9170412
OpenAlexW4281853964

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.